title: [Myopathies and malignancy].
abstract: There is a greater risk of developing cancer among patients with inflammatory myositis, specifically dermatomyositis. This relationship was first described in 1916 by Sterz and has been corroborated in population based studies. This chapter describes clinical and serological characteristics of patients with myositis and cancer, as well as the most common malignancies and diagnostic and prognostic considerations in this group of patients.
authors.affiliation: Servicio de Reumatología, Centro Médico Nacional 20 de Noviembre, ISSSTE, México D. F., México; Universidad Nacional Autónoma de México, México D. F., México. liliaandrade@prodigy.net.mx
authors.forename: Lilia
authors.initials: L
authors.lastname: Andrade-Ortega